CME Group (NASDAQ:CME) Coverage Initiated at TD Cowen

Equities research analysts at TD Cowen assumed coverage on shares of CME Group (NASDAQ:CME) in a report released on Thursday, MarketBeat.com reports. The firm set a “hold” rating and a $221.00 price target on the financial services provider’s stock. TD Cowen’s target price would indicate a potential upside of 1.24% from the stock’s current price.

A number of other equities research analysts have also recently issued reports on the company. Bank of America cut CME Group from a “neutral” rating to an “underperform” rating and reduced their price objective for the stock from $212.00 to $177.00 in a report on Tuesday, September 3rd. Barclays boosted their price target on CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a research note on Thursday, July 25th. Keefe, Bruyette & Woods boosted their price target on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research note on Thursday, July 25th. Piper Sandler reiterated an “overweight” rating and issued a $225.00 price target on shares of CME Group in a research note on Tuesday, August 20th. Finally, JPMorgan Chase & Co. boosted their price target on CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $212.54.

CME Group Price Performance

Shares of NASDAQ CME opened at $218.30 on Thursday. CME Group has a twelve month low of $190.70 and a twelve month high of $223.80. The company has a market cap of $78.60 billion, a PE ratio of 24.84, a price-to-earnings-growth ratio of 8.74 and a beta of 0.55. The business’s 50 day moving average price is $209.33 and its two-hundred day moving average price is $207.56. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. During the same quarter in the previous year, the company posted $2.30 earnings per share. The business’s revenue was up 12.7% on a year-over-year basis. On average, analysts predict that CME Group will post 9.94 EPS for the current year.

Insider Transactions at CME Group

In other news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The disclosure for this sale can be found here. Company insiders own 0.30% of the company’s stock.

Institutional Trading of CME Group

A number of institutional investors have recently bought and sold shares of the company. B. Riley Wealth Advisors Inc. increased its stake in CME Group by 1.3% in the 4th quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock valued at $782,000 after buying an additional 48 shares during the last quarter. Capital Advisors Ltd. LLC boosted its holdings in CME Group by 4.3% in the 1st quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock valued at $250,000 after purchasing an additional 48 shares during the period. Lantz Financial LLC lifted its holdings in shares of CME Group by 1.1% during the 1st quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock worth $982,000 after acquiring an additional 49 shares during the last quarter. Lester Murray Antman dba SimplyRich lifted its holdings in shares of CME Group by 0.7% during the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after acquiring an additional 50 shares during the last quarter. Finally, Greystone Financial Group LLC lifted its holdings in shares of CME Group by 1.6% during the 4th quarter. Greystone Financial Group LLC now owns 3,282 shares of the financial services provider’s stock worth $691,000 after acquiring an additional 52 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.